High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$12.7M
$12,727,717
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-10 | $101,285x2 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-10 | $285,673 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-09 | $240,664x2 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-09 | $457,617 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-06 | $240,664x2 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-06 | $468,447 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
LO FRANCIS
• Officer • Chief People Officer
Sell to CoverΔOwn -10.6%
2026-03-05
$574,537
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief People Officer
Sell to CoverΔOwn -10.6%
|
2026-03-05 | $574,537 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-05 | $240,664x2 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-05 | $495,056 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-04 | $240,664x2 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-04 | $513,621 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
Director
Other
|
2026-03-03 | $191,696 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
GRIFFIN MICHELLE RENEE
• Director
10b5-1 SellΔOwn -75.7%
2026-03-03
$735,073
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Director
10b5-1 SellΔOwn -75.7%
|
2026-03-03 | $735,073 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $823,826x2 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-03-03
$235,129
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-03-03 | $235,129 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
Other
|
2026-03-03 | $240,664x2 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
COO
10b5-1 Sell
|
2026-03-03 | $484,751x2 | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS CHAD M
• CEO
10b5-1 SellΔOwn -12.7%
2026-03-02
$4,572,360Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 SellΔOwn -12.7%
|
2026-03-02 | $4,572,360Large | S | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
ROBINS HARLAN S
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-03-02
$157,200
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-03-02 | $157,200 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CEO
10b5-1 Sell
|
2026-02-27 | $2,924,427Large | S | Form 4 |